The first-ever platform trial for ALS is set to kick off this month and is led by investigators at the Sean M. Healey & AMG Center for ALS at Mass General Hospital Aural Analytics’ award-winning clinical trials platform will provide speech collection and...
Leading neurobiologist Dr. Greg Hickok, neuroscientist Dr. Robert Bowser, FDA and regulatory expert Michele Chin-Purcell and data analytics strategist Tyler Knutson added to the board SCOTTSDALE, Ariz. — FEB 6, 2020 — Aural Analytics, Inc., a privately held digital...
SCOTTSDALE, ARIZ. – DEC. 9, 2019 – Aural Analytics, Inc., a privately held digital health company developing the world’s most advanced speech analytics platform, today announced its participation in the Consumer Technology Association (CTA) initiative to define new...
The TGen-sponsored clinical trial in recently-diagnosed ALS patients will integrate the Aural Analytics speech analytics platform technology DENVER and SCOTTSDALE, Ariz. – NOV. 7, 2019 Aural Analytics, Inc., a privately-held digital health company focused on building...
DENVER and SCOTTSDALE, Ariz., Nov. 4, 2019 /PRNewswire/ — The ALS Never Surrender Foundation, a volunteer-based, non-profit organization seeking to cure Motor Neuron Disease (MND) and Amyotrophic Lateral Sclerosis (ALS), today announced...